跳至主要内容
临床试验/NCT02826083
NCT02826083已完成不适用

Randomized, Double-blind Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia and on Lipoprotein Kinetics

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2014年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
1
主要终点
Quantification of Malondialdehyde (MDA)

研究概览

简要总结

Given preliminary data in animal (proprietary data) have shown that XXS (a mixture of natural polyphenolic extracts of edible plants) has a significant and favourable effect on oxidative stress notably with a decrease in certain markers of oxidative stress and on plasma lipid parameters, the investigator proposes to study the effect of 6 months of treatment with XXS in a controlled study against placebo in a population of persons presenting a lipid profile at the upper limit of normal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Persons who have provided written consent
  • •Persons aged over 18 years
  • •Presenting LDL levels between 1.30 and 1.90 g/l and/or triglyceride levels between 1.5 and 3 g/l

排除标准

  • •Persons without national health insurance cover
  • •Pregnant or breastfeeding women
  • •Adults under guardianship
  • •Patients with diabetes (Insulin-Dependent Diabetes (IDD) or Non-Insulin-Dependent Diabetes NIDD)
  • •Patients with coronary artery disease
  • •Patients with atherosclerosis
  • •HDL>0.80 g/l
  • •receiving treatment with lipid-lowering agents (statins, fibrates, ezetimibe or Ω3)
  • •Consuming vitamin supplements (A, C, E…)
  • •Consuming oligoelements or minerals (Se, Zn, Ca…)
  • •Renal insufficiency (creatinine clearance < 30 ml/min calculated according to the Modification of the Diet in Renal Disease (MDRD))

研究组 & 干预措施

XXS

Experimental

干预措施: XXS (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: non-XXS (Dietary Supplement)

结局指标

主要结局

Quantification of Malondialdehyde (MDA)

时间窗: Change from baseline at 1 month, 3 months, 6 months after treatment with XXS

Quantification of oxidized Low Density Lipoprotein (LDL)

时间窗: Change from baseline at 1 month, 3 months, 6 months after treatment with XXS

次要结局

  • Measure of overall free-radical defences in the blood by KRL Kyrial Internationaltest(Change from baseline at 1 month, 3 months, 6 months after treatment with XXS)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验